Gizem Teker, MD

Boston, MA, United States

Dr. Gizem Teker received her medical degree from Istanbul University Faculty of Medicine in Turkey. She is a physician with a strong interest in endocrinology, and specifically bone metabolism and osteoporosis. Dr. Teker is currently on a leave while continuing her academic and research activities to pursue her cancer treatment. At ENDO 2026, she is presenting her research, Cardiovascular Safety of Romosozumab Versus Alendronate in Postmenopausal Women with Severe Osteoporosis, as both a poster presentation and a rapid-fire presentation.

Disclosure information not submitted.

Presentation(s):

• SUN-791 - Comparative Real-World Outcomes of Bisphosphonate Monotherapy Versus Combined Testosterone and Bisphosphonate Therapy in Hypogonadal Men with Osteoporosis

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-792 - Comparative Risk of Major Osteoporotic Fracture with Bisphosphonates Versus Denosumab in Hypogonadal Men: A Real-World Analysis

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-811 - Cardiovascular Safety of Romosozumab Versus Alendronate in Postmenopausal Women with Severe Osteoporosis

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF43-02 - Cardiovascular Safety of Romosozumab Versus Alendronate in Postmenopausal Women with Severe Osteoporosis

  Monday, June 15, 2026
  9:35 AM - 9:40 AM CT